Accuracy in skin cancer diagnosis: a retrospective study of an Australian public hospital dermatology department

The Australasian Journal of Dermatology
Heidi M Rolfe

Abstract

Accurate identification of skin lesions is vital in ensuring malignancies are not missed and that they are treated early to avoid mortality. It is also important that appropriate lesions are submitted for biopsy to decrease the costs and morbidity associated with the unnecessary removal of benign lesions. This study attempted to assess current accuracy in skin cancer diagnosis. Histology reports for all biopsies and excisions performed in an 18-month period at a public hospital dermatology department were reviewed. Dermatology registrars and consultants were involved in assessing lesions for biopsy. Calculations were made to quantify the sensitivity of melanoma diagnosis; naevi to melanoma ratio (NMR); biopsy to treatment ratio (BTR), and number needed to treat for melanoma (NNT). NNT was calculated as the number of pigmented lesions (seborrhoeic keratoses, naevi and melanoma) removed to identify one melanoma. 6546 biopsies/excisions were performed, identifying 55 melanomas. The sensitivity of melanoma diagnosis was 76% and 11% of melanomas were thought to be dysplastic naevi. The NMR was 6.4. The BTR was 1.97, indicating that one in every 1.97 biopsies was identified as a non-melanoma skin cancer. The NNT was 11.9. All dysplas...Continue Reading

References

May 1, 1997·Journal of the American Academy of Dermatology·R MarksA P Dorevitch
Nov 27, 1998·The Medical Journal of Australia·P F HanrahanC A D'Este
Apr 3, 1999·Journal of the American Academy of Dermatology·J M Grant-KelsC M Grin
Apr 25, 2000·Postgraduate Medical Journal·A M JacksonR Ellison
Dec 26, 2001·Archives of Dermatology·S W MenziesW H McCarthy
Mar 21, 2002·The Lancet Oncology·H KittlerM Binder
May 8, 2003·Journal of the American Academy of Dermatology·Giuseppe ArgenzianoAlfred W Kopf
Aug 2, 2003·The British Journal of Dermatology·R SchiffnerW Stolz
Jan 8, 2004·The Medical Journal of Australia·Dallas R EnglishRobert C Burton
Jan 21, 2004·Archives of Dermatology·June K Robinson, Brian J Nickoloff
Jan 20, 2005·The British Journal of Dermatology·J BauerC Garbe
Feb 24, 2006·The Medical Journal of Australia·David WilkinsonAnthony Dixon
Sep 20, 2006·Archives of Dermatology·Harald KittlerScott Menzies
Feb 21, 2007·The Medical Journal of Australia·Deborah A AskewGordon L Patrick
Oct 2, 2007·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Stanley R FullerDouglas Grossman
Jan 12, 2008·The Australasian Journal of Dermatology·Alvin L K ChiaStephen Shumack
Aug 12, 2009·Journal of the American Academy of Dermatology·Craig HansenGiuseppe Argenziano
Sep 25, 2009·International Journal of Dermatology·Temitope F SoaresDavid L Swanson
Apr 6, 2011·Journal of the American College of Surgeons·Jonathan S ZagerStephen R Grobmyer

❮ Previous
Next ❯

Citations

Jan 3, 2018·The Australasian Journal of Dermatology·Lisa M Abbott, Saxon D Smith
Mar 5, 2019·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·James A SolomonMurad Alam
Sep 16, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·A T CongaltonR C W Martin
Dec 24, 2019·The Australasian Journal of Dermatology·Sara Lee de MenezesVictoria Jane Mar
Jun 21, 2016·The American Journal of Dermatopathology·Wolfgang Weyers
Feb 15, 2014·Clinical and Experimental Dermatology·B EsdaileJ Bowling
May 2, 2020·Optics Letters·Urs A T HofmannDaniel Razansky
Aug 2, 2017·Applied Health Economics and Health Policy·Thomas M ElliottLouisa G Gordon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.